Neurolixis' Unattributed Round

Neurolixis raised a round of funding on July 18, 2013.

Neurolixis is an early-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of human central nervous system diseases including Parkins…

Articles about Neurolixis' Unattributed Round: